Support for this idea comes from studies using SIRT2, an antitumor and lifespan-extending protein, which activates the APC by deacetylating CDC20 and CDH1; SIRT2-deficient mice exhibited higher levels of cancer and elevated levels of APC substrates [83]. The gene discussed is CDH1; the disease is cancer.